In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using ...
A NEW test that can help predict how people will respond to weight loss medications has been developed. It suggests that certain eaters may get on better with fat jabs. The test estimates an ...
It has been used in clinical trials of two FDA-approved medications: a first-generation weight loss drug, phentermine-topiramate, and a newer GLP-1 drug called liraglutide. Those with a high satiation ...
Social determinants of health disproportionately impact patients' ability to maintain and achieve their weight loss goals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results